Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants.

Zorrilla CD, Van Dyke R, Bardeguez A, Acosta EP, Smith B, Hughes MD, Huang S, Watts DH, Heckman B, Jiménez E, McSherry G, Mofenson L.

Antimicrob Agents Chemother. 2007 Jun;51(6):2208-10.

2.

Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy.

Ghosn J, De Montgolfier I, Cornélie C, Dominguez S, Pérot C, Peytavin G, Marcelin AG, Pauchard M, Ouagari Z, Bonmarchand M, Agher R, Calvez V, Bricaire F, Dommergues M, Katlama C, Tubiana R.

Antimicrob Agents Chemother. 2008 Apr;52(4):1542-4. doi: 10.1128/AAC.01301-07.

3.
4.

Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy.

Lopez-Cortes LF, Ruiz-Valderas R, Rivero A, Camacho A, Marquez-Solero M, Santos J, García-Lazaro M, Viciana P, Rodriguez-Baños J, Ocampo A.

Ther Drug Monit. 2007 Apr;29(2):171-6.

PMID:
17417070
5.

A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients.

Ananworanich J, Hill A, Siangphoe U, Ruxrungtham K, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, Nuesch R, Cooper DA, Hirschel B; Staccato Study Group..

Antivir Ther. 2005;10(6):761-7.

PMID:
16218176
6.

Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?

Sibiude J, Warszawski J, Tubiana R, Dollfus C, Faye A, Rouzioux C, Teglas JP, Ekoukou D, Blanche S, Mandelbrot L.

Clin Infect Dis. 2012 May;54(9):1348-60. doi: 10.1093/cid/cis198.

PMID:
22460969
7.

The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group.

Gisolf EH, Jurriaans S, Pelgrom J, van Wanzeele F, van der Ende ME, Brinkman K, Borst MJ, de Wolf F, Japour AJ, Danner SA.

AIDS. 2000 Mar 10;14(4):405-13.

PMID:
10770543
8.

Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children.

Ananworanich J, Kosalaraksa P, Hill A, Siangphoe U, Bergshoeff A, Pancharoen C, Engchanil C, Ruxrungtham K, Burger D; HIV-NAT 017 Study Team..

Pediatr Infect Dis J. 2005 Oct;24(10):874-9.

PMID:
16220084
9.

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL; South African Intrapartum Nevirapine Trial (SAINT) Investigators..

J Infect Dis. 2003 Mar 1;187(5):725-35.

PMID:
12599045
10.

Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.

von Hentig N, Nisius G, Lennemann T, Khaykin P, Stephan C, Babacan E, Staszewski S, Kurowski M, Harder S, Haberl A.

Antivir Ther. 2008;13(8):1039-46.

PMID:
19195329
11.

Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohort.

Brunet C, Reliquet V, Jovelin T, Venisse N, Winer N, Bui E, Le Moal G, Perfezou P, De Saint Martin L, Raffi F.

Med Mal Infect. 2012 Sep;42(9):421-8. doi: 10.1016/j.medmal.2012.07.010.

PMID:
22938775
12.

Ritonavir and saquinavir combination therapy for the treatment of HIV infection.

Cameron DW, Japour AJ, Xu Y, Hsu A, Mellors J, Farthing C, Cohen C, Poretz D, Markowitz M, Follansbee S, Angel JB, McMahon D, Ho D, Devanarayan V, Rode R, Salgo M, Kempf DJ, Granneman R, Leonard JM, Sun E.

AIDS. 1999 Feb 4;13(2):213-24.

PMID:
10202827
13.
14.

Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission.

Vithayasai V, Moyle GJ, Supajatura V, Wattanatchariya N, Kanshana S, Sirichthaporn P, Dabtham K, Somburanasin P, Chantawuttinan T, Hill AM, Hawkins D.

J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):410-2.

PMID:
12138347
15.

Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.

Cameron DW, Becker S, King MS, da Silva B, Klein C, Tokimoto D, Foit C, Calhoun D, Bernstein B, Hanna GJ.

J Antimicrob Chemother. 2007 May;59(5):957-63.

PMID:
17350990
16.

Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients.

Bickel M, Bodtländer A, Knecht GK, Stephan C, von Hentig N, Kurowski M, Gute P, Klauke S, Lutz T.

J Antimicrob Chemother. 2009 Dec;64(6):1260-4. doi: 10.1093/jac/dkp348.

PMID:
19776037
17.

Once-daily saquinavir and ritonavir in treatment-experienced HIV-1-infected individuals.

Soria A, Gianotti N, Cernuschi M, Lazzarin A.

New Microbiol. 2004 Jan;27(1):11-5.

PMID:
14964400
18.

Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.

Michelet C, Bellissant E, Ruffault A, Arvieux C, Delfraissy JF, Raffi F, Bazin C, Renard I, Sébille V, Chauvin JP, Dohin E, Cartier F.

Clin Pharmacol Ther. 1999 Jun;65(6):661-71.

PMID:
10391672
19.

A randomized controlled trial to assess safety, tolerability, and antepartum viral load with increased lopinavir/ritonavir dosage in pregnancy.

Bonafe SM, Costa DA, Vaz MJ, Senise JF, Pott-Junior H, Machado RH, Castelo A.

AIDS Patient Care STDS. 2013 Nov;27(11):589-95. doi: 10.1089/apc.2013.0159.

20.

The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome.

Clarke SM, Mulcahy F, Healy CM, Condon S, Butler KM.

Int J STD AIDS. 2000 Apr;11(4):220-3.

PMID:
10772084

Supplemental Content

Support Center